Universal Health Services, Inc. (0LJL.L)
USD 181.27
(-0.29%)
USD 181.27
(-0.29%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.74 Billion USD | 10.69% |
| 2022 | 1.64 Billion USD | -17.55% |
| 2021 | 1.92 Billion USD | 2.21% |
| 2020 | 1.87 Billion USD | 8.69% |
| 2019 | 1.8 Billion USD | 4.68% |
| 2018 | 1.65 Billion USD | -4.95% |
| 2017 | 1.72 Billion USD | 1.77% |
| 2016 | 1.69 Billion USD | 2.41% |
| 2015 | 1.65 Billion USD | 12.4% |
| 2014 | 1.47 Billion USD | 10.35% |
| 2013 | 1.35 Billion USD | 6.65% |
| 2012 | 1.23 Billion USD | 5.07% |
| 2011 | 1.18 Billion USD | 63.49% |
| 2010 | 724.12 Million USD | 0.61% |
| 2009 | 720.35 Million USD | 28.29% |
| 2008 | 604.71 Million USD | 2.08% |
| 2007 | 550.16 Million USD | 73.61% |
| 2006 | 655.07 Million USD | -43.15% |
| 2005 | 477.75 Million USD | 11.89% |
| 2004 | 501.44 Million USD | -0.54% |
| 2003 | 981.12 Million USD | 11.46% |
| 2002 | 454.3 Million USD | 3.55% |
| 2001 | 387.97 Million USD | 37.36% |
| 2000 | 310.28 Million USD | 15.69% |
| 1999 | 269.6 Million USD | 3.85% |
| 1998 | 264.7 Million USD | 28.5% |
| 1997 | 206 Million USD | 13.62% |
| 1996 | 176.2 Million USD | 30.62% |
| 1995 | 127.2 Million USD | 45.19% |
| 1994 | 95.6 Million USD | 14.77% |
| 1993 | 83.3 Million USD | -17.85% |
| 1992 | 101.4 Million USD | 39.67% |
| 1991 | 73 Million USD | -18.07% |
| 1990 | 89.1 Million USD | 13.21% |
| 1989 | 78.7 Million USD | -4.49% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 583.87 Million USD | 10.21% |
| 2024 Q3 | 528.56 Million USD | -8.24% |
| 2024 Q1 | 529.76 Million USD | 11.14% |
| 2023 Q3 | 420.58 Million USD | 0.8% |
| 2023 Q1 | 406.59 Million USD | -1.92% |
| 2023 Q2 | 417.27 Million USD | 2.62% |
| 2023 FY | - USD | 10.69% |
| 2023 Q4 | 476.67 Million USD | 13.34% |
| 2022 Q2 | 379.25 Million USD | 3.78% |
| 2022 Q4 | 414.57 Million USD | -0.28% |
| 2022 FY | - USD | -17.55% |
| 2022 Q1 | 365.44 Million USD | -20.44% |
| 2022 Q3 | 415.73 Million USD | 9.62% |
| 2021 Q2 | 582.08 Million USD | 36.56% |
| 2021 Q1 | 426.23 Million USD | -23.37% |
| 2021 Q3 | 442.55 Million USD | -23.97% |
| 2021 FY | - USD | 2.21% |
| 2021 Q4 | 459.32 Million USD | 3.79% |
| 2020 Q1 | 351.52 Million USD | -27.96% |
| 2020 Q4 | 556.19 Million USD | 17.39% |
| 2020 Q3 | 473.8 Million USD | -2.78% |
| 2020 Q2 | 487.33 Million USD | 38.63% |
| 2020 FY | - USD | 8.69% |
| 2019 Q2 | 474.46 Million USD | 4.05% |
| 2019 Q1 | 455.97 Million USD | 24.79% |
| 2019 FY | - USD | 4.68% |
| 2019 Q3 | 301.05 Million USD | -36.55% |
| 2019 Q4 | 487.97 Million USD | 62.09% |
| 2018 Q4 | 365.39 Million USD | -4.06% |
| 2018 FY | - USD | -4.95% |
| 2018 Q2 | 449.35 Million USD | 0.54% |
| 2018 Q1 | 446.94 Million USD | -1.23% |
| 2018 Q3 | 380.85 Million USD | -15.24% |
| 2017 FY | - USD | 1.77% |
| 2017 Q3 | 367.52 Million USD | -17.09% |
| 2017 Q4 | 452.5 Million USD | 23.12% |
| 2017 Q2 | 443.3 Million USD | -4.61% |
| 2017 Q1 | 464.73 Million USD | 10.21% |
| 2016 Q2 | 434.69 Million USD | -5.58% |
| 2016 Q4 | 421.66 Million USD | 10.59% |
| 2016 FY | - USD | 2.41% |
| 2016 Q1 | 460.37 Million USD | 8.4% |
| 2016 Q3 | 381.28 Million USD | -12.29% |
| 2015 Q2 | 432.64 Million USD | 1.55% |
| 2015 FY | - USD | 12.4% |
| 2015 Q3 | 374.59 Million USD | -13.42% |
| 2015 Q4 | 424.71 Million USD | 13.38% |
| 2015 Q1 | 426.05 Million USD | 1.34% |
| 2014 Q3 | 306.23 Million USD | -20.28% |
| 2014 Q2 | 384.12 Million USD | 5.43% |
| 2014 Q1 | 364.33 Million USD | 11.44% |
| 2014 FY | - USD | 10.35% |
| 2014 Q4 | 420.4 Million USD | 37.28% |
| 2013 Q2 | 385.8 Million USD | 19.13% |
| 2013 Q1 | 323.84 Million USD | -7.5% |
| 2013 FY | - USD | 6.65% |
| 2013 Q4 | 326.92 Million USD | 4.83% |
| 2013 Q3 | 311.85 Million USD | -19.17% |
| 2012 Q3 | 276.82 Million USD | -9.3% |
| 2012 Q1 | 342.84 Million USD | 20.47% |
| 2012 Q4 | 350.11 Million USD | 26.48% |
| 2012 FY | - USD | 5.07% |
| 2012 Q2 | 305.21 Million USD | -10.98% |
| 2011 Q2 | 305.66 Million USD | -7.92% |
| 2011 Q1 | 331.93 Million USD | 72.85% |
| 2011 Q3 | 270.78 Million USD | -11.41% |
| 2011 Q4 | 284.6 Million USD | 5.1% |
| 2011 FY | - USD | 63.49% |
| 2010 Q3 | 160.21 Million USD | -12.82% |
| 2010 FY | - USD | 0.61% |
| 2010 Q4 | 192.03 Million USD | 19.86% |
| 2010 Q1 | 194.05 Million USD | 14.06% |
| 2010 Q2 | 183.77 Million USD | -5.3% |
| 2009 Q2 | 214.12 Million USD | 13.97% |
| 2009 FY | - USD | 28.29% |
| 2009 Q4 | 170.14 Million USD | 11.14% |
| 2009 Q3 | 153.08 Million USD | -28.51% |
| 2009 Q1 | 187.88 Million USD | 40.72% |
| 2008 Q2 | 161.54 Million USD | -7.37% |
| 2008 Q1 | 174.4 Million USD | 28.27% |
| 2008 FY | - USD | 2.08% |
| 2008 Q3 | 122.51 Million USD | -24.16% |
| 2008 Q4 | 133.51 Million USD | 8.98% |
| 2007 FY | - USD | 73.61% |
| 2007 Q4 | 135.96 Million USD | 20.18% |
| 2007 Q1 | 150.21 Million USD | 31.16% |
| 2007 Q2 | 154.47 Million USD | 2.83% |
| 2007 Q3 | 113.13 Million USD | -26.76% |
| 2006 FY | - USD | -43.15% |
| 2006 Q3 | -18.87 Million USD | -116.49% |
| 2006 Q1 | 108.81 Million USD | -21.36% |
| 2006 Q2 | 114.49 Million USD | 5.21% |
| 2006 Q4 | 114.53 Million USD | 706.82% |
| 2005 FY | - USD | 11.89% |
| 2005 Q4 | 138.37 Million USD | -12.7% |
| 2005 Q3 | 158.5 Million USD | 39.46% |
| 2005 Q2 | 113.65 Million USD | -27.4% |
| 2005 Q1 | 156.54 Million USD | 32.15% |
| 2004 FY | - USD | -0.54% |
| 2004 Q2 | 132.65 Million USD | 2.61% |
| 2004 Q3 | 120.71 Million USD | -9.0% |
| 2004 Q4 | 118.46 Million USD | -1.87% |
| 2004 Q1 | 129.28 Million USD | 6.12% |
| 2003 Q2 | 134.77 Million USD | -1.0% |
| 2003 Q3 | 122.28 Million USD | -15.08% |
| 2003 FY | - USD | 11.46% |
| 2003 Q4 | 123.73 Million USD | 6.44% |
| 2003 Q1 | 133.13 Million USD | 20.84% |
| 2002 Q4 | 114.88 Million USD | 2.93% |
| 2002 FY | - USD | 3.55% |
| 2002 Q1 | 116.17 Million USD | -19.33% |
| 2002 Q2 | 114.06 Million USD | -1.41% |
| 2002 Q3 | 109.18 Million USD | -4.26% |
| 2001 Q3 | 93.76 Million USD | -3.52% |
| 2001 Q2 | 97.31 Million USD | -4.57% |
| 2001 Q4 | 96.37 Million USD | 53.12% |
| 2001 FY | - USD | 37.36% |
| 2001 Q1 | 100.52 Million USD | 29.11% |
| 2000 Q4 | 78.96 Million USD | 6.98% |
| 2000 Q1 | 82.36 Million USD | 33.27% |
| 2000 Q2 | 75.14 Million USD | -8.76% |
| 2000 Q3 | 73.81 Million USD | -1.77% |
| 2000 FY | - USD | 15.69% |
| 1999 Q2 | 73.5 Million USD | -13.73% |
| 1999 Q1 | 85.2 Million USD | 26.04% |
| 1999 FY | - USD | 3.85% |
| 1999 Q4 | 61.8 Million USD | 25.35% |
| 1999 Q3 | 49.3 Million USD | -32.93% |
| 1998 Q1 | 72.3 Million USD | 44.89% |
| 1998 FY | - USD | 28.5% |
| 1998 Q3 | 56.1 Million USD | -18.22% |
| 1998 Q4 | 67.6 Million USD | 20.5% |
| 1998 Q2 | 68.6 Million USD | -5.12% |
| 1997 Q4 | 49.9 Million USD | 7.31% |
| 1997 FY | - USD | 13.62% |
| 1997 Q1 | 58 Million USD | 16.47% |
| 1997 Q2 | 51.6 Million USD | -11.03% |
| 1997 Q3 | 46.5 Million USD | -9.88% |
| 1996 Q2 | 41.9 Million USD | -3.9% |
| 1996 Q1 | 43.6 Million USD | 10.38% |
| 1996 FY | - USD | 30.62% |
| 1996 Q4 | 49.8 Million USD | 18.57% |
| 1996 Q3 | 42 Million USD | 0.24% |
| 1995 Q2 | 27.7 Million USD | -13.98% |
| 1995 FY | - USD | 45.19% |
| 1995 Q4 | 39.5 Million USD | 41.58% |
| 1995 Q3 | 27.9 Million USD | 0.72% |
| 1995 Q1 | 32.2 Million USD | 60.2% |
| 1994 Q1 | 28.5 Million USD | 59.22% |
| 1994 Q2 | 25 Million USD | -12.28% |
| 1994 Q3 | 22 Million USD | -12.0% |
| 1994 Q4 | 20.1 Million USD | -8.64% |
| 1994 FY | - USD | 14.77% |
| 1993 Q2 | 21.1 Million USD | -15.26% |
| 1993 Q3 | 19.4 Million USD | -8.06% |
| 1993 Q4 | 17.9 Million USD | -7.73% |
| 1993 FY | - USD | -17.85% |
| 1993 Q1 | 24.9 Million USD | 42.29% |
| 1992 FY | - USD | 39.67% |
| 1992 Q4 | 17.5 Million USD | 2.94% |
| 1992 Q3 | 17 Million USD | -22.02% |
| 1992 Q2 | 21.8 Million USD | -51.34% |
| 1992 Q1 | 44.8 Million USD | 307.27% |
| 1991 Q3 | 15.7 Million USD | -24.52% |
| 1991 Q4 | 11.1 Million USD | -29.94% |
| 1991 Q2 | 20.9 Million USD | -17.79% |
| 1991 FY | - USD | -18.15% |
| 1991 Q1 | 25.4 Million USD | 50.6% |
| 1990 FY | - USD | 13.14% |
| 1990 Q2 | 20.7 Million USD | -87.57% |
| 1990 Q4 | 16.9 Million USD | -4.0% |
| 1990 Q1 | 166.5 Million USD | 141.45% |
| 1990 Q3 | 17.5 Million USD | -15.46% |
| 1989 FY | - USD | -6.11% |
| 1989 Q3 | 140.2 Million USD | -4.63% |
| 1989 Q1 | 153.5 Million USD | 141.04% |
| 1989 Q2 | 147 Million USD | -4.23% |
| 1989 Q4 | -401.7 Million USD | -386.52% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phreesia, Inc. | -102.94 Million USD | 1793.547% |
| Accuray Incorporated | 9 Million USD | -19252.004% |
| Align Technology, Inc. | 799.03 Million USD | -118.19% |
| Elevance Health Inc. | 10.49 Billion USD | 83.38% |
| AxoGen, Inc. | -13.32 Million USD | 13180.897% |
| Boston Scientific Corporation | 3.61 Billion USD | 51.746% |
| CVS Health Corporation | 18.17 Billion USD | 90.409% |
| Cardinal Health, Inc. | 1.97 Billion USD | 11.859% |
| Centene Corporation | -463 Million USD | 476.549% |
| DaVita Inc. | 2.34 Billion USD | 25.699% |
| HCA Healthcare, Inc. | 12.72 Billion USD | 86.295% |
| Hologic, Inc. | 1.29 Billion USD | -34.503% |
| Humana Inc. | -561 Million USD | 410.77% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | -43.177% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | -29.2% |
| Masimo Corporation | 236.7 Million USD | -636.553% |
| McKesson Corporation | 4.66 Billion USD | 62.644% |
| Patterson Companies, Inc. | 374.75 Million USD | -365.215% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | -0.659% |
| ResMed Inc. | 1.6 Billion USD | -8.941% |
| Henry Schein, Inc. | 943 Million USD | -84.88% |
| Teladoc Health, Inc. | 153.99 Million USD | -1032.114% |
| Veeva Systems Inc. | 429.33 Million USD | -306.076% |
| Baxter International Inc. | 2.77 Billion USD | 37.197% |
| Becton, Dickinson and Company | 4.27 Billion USD | 59.218% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 27.178% |
| Danaher Corporation | 7.49 Billion USD | 76.751% |
| Stryker Corporation | 5.16 Billion USD | 66.213% |
| Medtronic plc | 9.05 Billion USD | 80.748% |